[1]
“New treatment approaches in relapsing/refractory primary central nervous system lymphomas”, Ann Med Res , vol. 29, no. 11, pp. 1205–1208, Nov. 2022, Accessed: Apr. 26, 2025. [Online]. Available: http://annalsmedres.org/index.php/aomr/article/view/4118